| __timestamp | Travere Therapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28203205 | 4320000 |
| Thursday, January 1, 2015 | 99892000 | 2538000 |
| Friday, January 1, 2016 | 133591000 | 3337000 |
| Sunday, January 1, 2017 | 154937000 | 4003000 |
| Monday, January 1, 2018 | 164246000 | 8386000 |
| Tuesday, January 1, 2019 | 175338000 | 4461000 |
| Wednesday, January 1, 2020 | 198321000 | 1050000 |
| Friday, January 1, 2021 | 227490000 | 2963000 |
| Saturday, January 1, 2022 | 212018000 | 1772000 |
| Sunday, January 1, 2023 | 145238000 | 314000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and potential. Over the past decade, Travere Therapeutics, Inc. has demonstrated a robust revenue trajectory, with a remarkable increase of over 400% from 2014 to 2021. This growth peaked in 2021, with revenues reaching their zenith. However, 2023 saw a decline, bringing revenues down by approximately 36% from the previous year.
In contrast, Viridian Therapeutics, Inc. has experienced a more volatile revenue journey. Starting with modest figures in 2014, the company saw its highest revenue in 2018, only to face a significant downturn in subsequent years, culminating in a 92% drop by 2023. This analysis highlights the contrasting paths of these two companies, offering insights into the challenges and opportunities within the biotech sector.
Revenue Showdown: Pfizer Inc. vs Viridian Therapeutics, Inc.
Revenue Showdown: Bristol-Myers Squibb Company vs Viridian Therapeutics, Inc.
Revenue Showdown: argenx SE vs Viridian Therapeutics, Inc.
Revenue Showdown: Teva Pharmaceutical Industries Limited vs Viridian Therapeutics, Inc.
Comparing Revenue Performance: BeiGene, Ltd. or Travere Therapeutics, Inc.?
Annual Revenue Comparison: BeiGene, Ltd. vs Viridian Therapeutics, Inc.
Who Generates More Revenue? BioMarin Pharmaceutical Inc. or Travere Therapeutics, Inc.
Exelixis, Inc. and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: TG Therapeutics, Inc. or Viridian Therapeutics, Inc.?
Revenue Showdown: HUTCHMED (China) Limited vs Viridian Therapeutics, Inc.
Ligand Pharmaceuticals Incorporated or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Revenue Showdown: Mesoblast Limited vs Viridian Therapeutics, Inc.